January 30, 2019
Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
Read More
January 30, 2019
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
Read More
January 30, 2019
Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
Read More
January 30, 2019
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir
Read More
January 30, 2019
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Read More
January 30, 2019
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Read More
Load More
X